The Board of Scientific Counselors, National Institute for Occupational Safety and Health (NIOSH), 9953 [05-3889]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 39 / Tuesday, March 1, 2005 / Notices
cough sound index (CSI) can be used in
diagnostic applications.
Auscultatory Training System
Walter McKinney, et al.
U.S. Patent Application No. 10/135,964
filed April 29, 2002, Canadian
Application No. 2,382,786 filed April
22, 2002
CDC Reference No. I–037–00/0—
Research Tool
This auscultatory training apparatus
includes a database of prerecorded
physiological sounds (e.g., lung, bowel,
or heart sounds) stored on a computer
for playback. A user friendly, graphical
interface software program is stored on
the computer for use with a
conventional computer mouse. The
program allows a user to select
prerecorded sounds for playback. In
addition, the program is operable to
generate an inverse model of the
playback system in the form of a digital
filter. The inverse model processes the
selected sound to cancel the distortions
of the playback system so that the sound
is accurately reproduced. The program
also permits the extraction of a specific
sound component from a prerecorded
sound so that only the extracted sound
component is audible during playback.
As well as a teaching tool to instruct the
user on various body sounds, this
invention could have applications as a
diagnostic screening tool and as a
telemedicine tool.
Imaging/Motorized Nail Press:
Automated Instrumentation for the
Assessment of Peripheral Vascular
Function
Anne M. Brumfield, et al.
U.S. Patent Application No. 60/578,174
filed on June 8, 2004, Australia Patent
Application No. 2004203059 filed on
July 6, 2004, Canada Patent Application
No. 2,474,841
CDC Reference No. I–028–02—Research
Tool
The nail press test has been used by
clinicians to assess peripheral
circulatory function. Following a ten
second press of the fingernail, a visual
determination of the rate of blood flow
return is made, as evidenced by the
return of color to the fingernail. Far
from being standardized, the results of
the test are qualitative and subjective.
New instrumentation representing an
automated version of the nail press has
been built which utilizes a computercontrolled linear stepper motor to apply
the desired force level. Blood volume
and force measurements are acquired
before, during and after the press. This
VerDate jul<14>2003
14:21 Feb 28, 2005
Jkt 205001
non-invasive and painless test provides
physiologically relevant data while
standardizing the force application,
press duration, and the criteria for
determining the precise time of blood
flow return.
Dated: February 18, 2005.
James D. Seligman,
Associate Director for Program Services,
Centers for Disease Control and Prevention.
[FR Doc. 05–3891 Filed 2–28–05; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
9953
For Further Information Contact: Roger
Rosa, Executive Secretary, BSC, NIOSH, CDC,
200 Independence Avenue, SW., Room 715H,
Washington, DC 20201, telephone (202) 205–
7856, fax (202) 260–4464.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: February 25, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–3889 Filed 2–28–05; 8:45 am]
Centers for Disease Control and
Prevention
BILLING CODE 4163–19–P
The Board of Scientific Counselors,
National Institute for Occupational
Safety and Health (NIOSH)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following committee
meeting:
Name: Board of Scientific Counselors
(BSC), NIOSH.
Time and Date: 9 a.m.–3 p.m., March 23,
2005.
Place: Washington Court Hotel on Capital
Hill, 525 New Jersey Avenue, NW.,
Washington, DC 20001, telephone (202) 628–
2100, fax (202) 879–7918.
Status: Open to the public, limited only by
the space available. The meeting room
accommodates approximately 50 people.
Purpose: The Secretary, the Assistant
Secretary for Health, and by delegation the
Director, Centers for Disease Control and
Prevention, are authorized under Sections
301 and 308 of the Public Health Service Act
to conduct directly or by grants or contracts,
research, experiments, and demonstrations
relating to occupational safety and health and
to mine health. The Board of Scientific
Counselors, NIOSH shall provide guidance to
the Director, NIOSH on research and
preventions programs. Specifically, the Board
shall provide guidance on the Institute’s
research activities related to developing and
evaluating hypotheses, systematically
documenting findings and disseminating
results. The Board shall evaluate the degree
to which the activities of the NIOSH: (1)
Conform to appropriate scientific standards,
(2) address current, relevant needs, and (3)
produce intended results.
Matters to be Discussed: Agenda items
include a report from the Director of NIOSH;
proposed revisions to the National
Occupational Research Agenda;
collaborations with the Occupational Safety
and Health Administration; occupational
safety and health surveillance; the health
hazard evaluation program; and closing
remarks.
Agenda items are subject to change as
priorities dictate.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
National Institutes of Health
National Center for Complementary &
Alternative Medicine; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel; RFA AIDS.
Date: March 28, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Jeanette M. Hosseini,
Scientific Review Administrator, National
Center for Complementary and Alternative
Medicine, 6707 Democracy Blvd, Suite 401,
Bethesda, MD 20892, (301) 594–9096.
Name of Committee: National Center for
Complementary and Alternative Medicine
Special Emphasis Panel, Improving
Measurement Tools for Sternal Skin
Conductance and Hot Flashes SEP.
Date: April 22, 2005.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\01MRN1.SGM
01MRN1
]]>Agencies
[Federal Register Volume 70, Number 39 (Tuesday, March 1, 2005)]
[Notices]
[Page 9953]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-3889]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
The Board of Scientific Counselors, National Institute for
Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following committee meeting:
Name: Board of Scientific Counselors (BSC), NIOSH.
Time and Date: 9 a.m.-3 p.m., March 23, 2005.
Place: Washington Court Hotel on Capital Hill, 525 New Jersey
Avenue, NW., Washington, DC 20001, telephone (202) 628-2100, fax
(202) 879-7918.
Status: Open to the public, limited only by the space available.
The meeting room accommodates approximately 50 people.
Purpose: The Secretary, the Assistant Secretary for Health, and
by delegation the Director, Centers for Disease Control and
Prevention, are authorized under Sections 301 and 308 of the Public
Health Service Act to conduct directly or by grants or contracts,
research, experiments, and demonstrations relating to occupational
safety and health and to mine health. The Board of Scientific
Counselors, NIOSH shall provide guidance to the Director, NIOSH on
research and preventions programs. Specifically, the Board shall
provide guidance on the Institute's research activities related to
developing and evaluating hypotheses, systematically documenting
findings and disseminating results. The Board shall evaluate the
degree to which the activities of the NIOSH: (1) Conform to
appropriate scientific standards, (2) address current, relevant
needs, and (3) produce intended results.
Matters to be Discussed: Agenda items include a report from the
Director of NIOSH; proposed revisions to the National Occupational
Research Agenda; collaborations with the Occupational Safety and
Health Administration; occupational safety and health surveillance;
the health hazard evaluation program; and closing remarks.
Agenda items are subject to change as priorities dictate.
For Further Information Contact: Roger Rosa, Executive
Secretary, BSC, NIOSH, CDC, 200 Independence Avenue, SW., Room 715H,
Washington, DC 20201, telephone (202) 205-7856, fax (202) 260-4464.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: February 25, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 05-3889 Filed 2-28-05; 8:45 am]
BILLING CODE 4163-19-P
